Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Summary : The IPO consists of a fresh issue of up to Rs 1,100 crore by the company, which will be used…
Synopsis : The placebo effect is the well-known phenomenon of a person’s physical or mental health improving after taking a treatment with…
Summary : The DTAB has approved a list of OTC drugs which includes medicines like antifungal infections, analgesics (pain killers), cough syrups,…
Summary : The drug received conditional marketing authorisation in the UK from the MHRA in November Beximco Pharma has announced that the…
Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
Synopsis : Natco Pharma Limited and Biophore India Pharmaceuticals have received the license from the Medicines Patent Pool (MPP), Switzerland, to manufacture and…
Summary : The humble chickpea or chana, one of the first few crops introduced into agriculture around 10,000 years ago, has recently…
Synopsis : Prime Minister Narendra Modi has launched 35 different crop varieties with special attributes developed by the Indian Council of Agricultural…
Summary : An official statement said on Saturday that a state-run agricultural university in Jabalpur of Madhya Pradesh has developed new types…